Identifying undiagnosed diabetes in emergency department patients
Official title: FINDing Patients With Unknown Diabetes During Acute Medical Admission in a District General Hospital In Tameside (FIND-IT)
Run by Tameside General Hospital · NCT04653545 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether routine blood tests in emergency department patients over 30 can help find people with undiagnosed diabetes or glucose issues so they can get the right treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Tameside General Hospital Academic / other |
| Locations | 1 site (Ashton-under-Lyne, Greater Manchester) |
| Trial ID | NCT04653545 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 30 years and older who present to the emergency department or acute medical unit.
✕Probably not a fit
Patients under 30 years of age or those with type 1 diabetes will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to determine the prevalence of undiagnosed diabetes and impaired glucose tolerance in patients over 30 years old presenting to the accident and emergency department or acute medical unit. By screening patients using routine blood tests for HbA1c levels, the study seeks to identify those with glucose intolerance who may not yet be diagnosed. The findings will help ensure that identified patients receive appropriate treatment, potentially improving their health outcomes and reducing the burden on the NHS. The study will involve 10,000 consecutive patients to provide a comprehensive assessment of glucose intolerance in this population.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and treatment of diabetes, improving patient outcomes and reducing complications associated with the disease.
How similar studies have gone: Other studies have shown success in using routine blood tests for early identification of diabetes, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥30 years. * Males and female sex Exclusion Criteria: * Aged \<30 years. * Type 1 diabetes
Where it's running
-
Tameside Hospital NHS Foundation Trust
Ashton-under-Lyne, Greater Manchester, United Kingdom Recruiting
Study contacts
- Principal investigator: Edward Jude — Tameside and Glossop Integrated Care NHS FT
- Study coordinator: Edward Jude, MD
- Email: edward.jude@tgh.nhs.uk
- Phone: +441619224451
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Occupation-based lifestyle program for adults with type 2 diabetes
A online program tests whether an occupation-focused lifestyle plan helps adults with type 2 diabetes manage daily routines and feel better in life.
-
Downhill walking training for type 2 diabetes
Researchers compare 8 weeks of downhill walking to level-ground walking in adults with type 2 diabetes to see which more improves walking ability and muscle and heart responses.
-
Normast 3 for adults with diabetic polyneuropathy
A 12-week trial will test whether Normast 3 helps reduce nerve pain in adults with diabetic polyneuropathy compared with a placebo.
-
Remote exercise program to improve blood sugar control and fitness in adults with type 2 diabetes
A remote 12‑week exercise program plus health education is tested in adults with type 2 diabetes to see if it improves blood sugar control and physical fitness.
-
Family-based wellness coaching to prevent type 2 diabetes in Peel
A family-focused wellness coaching program is being tested to see if it can reduce diabetes risk for South Asian and Black African/Caribbean families in Peel, Ontario.
-
Semaglutide Depot in Type 2 Diabetes: Safety, Tolerability, and How It Works
This study tests a long-acting form of semaglutide given every four weeks to adults with type 2 diabetes to see if it is safe and helps control blood sugar and weight.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.